Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RAD51L3 |
| Upstream (Parents) |
|---|
| (<<) BCAM → RAD51L3 |
| (<<) CASP2 → RAD51L3 |
| (<<) CCNB1 → RAD51L3 |
| (<<) CRKL → RAD51L3 |
| (<<) CRLF3 → RAD51L3 |
| (<<) DHX9 → RAD51L3 |
| (<<) DUSP9 → RAD51L3 |
| (<<) E2F7 → RAD51L3 |
| (<<) GNB4 → RAD51L3 |
| (<<) HLA-G → RAD51L3 |
| (<<) KLF6 → RAD51L3 |
| (<<) LGALS3 → RAD51L3 |
| (<<) MCL1 → RAD51L3 |
| (<<) MLX → RAD51L3 |
| (<<) NFIL3 → RAD51L3 |
| (<<) NOTCH2 → RAD51L3 |
| (<<) PLK1 → RAD51L3 |
| (<<) RDX → RAD51L3 |
| (<<) RFFL → RAD51L3 |
| (<<) RXRB → RAD51L3 |
| (<<) TAGLN2 → RAD51L3 |
| (<<) YWHAE → RAD51L3 |
| Downstream (Children) |
|---|
| RAD51L3 → CXADR (>>) |
| RAD51L3 → GRIN2D (>>) |
| RAD51L3 → INF2 (>>) |
| RAD51L3 → MPHOSPH6 (>>) |
| RAD51L3 → PITPNC1 (>>) |
| RAD51L3 → TSG101 (>>) |
